Suffolk man's death from fall in Great Yarmouth 'misadventure'
A man who fell from a building died as a result of misadventure, an inquest determined. Tom James, 26, died at Addenbrooke's Hospital, Cambridge, in June 2024 - 15 days after falling from a building in Great Yarmouth. Over a week-long inquest at Norfolk Coroner's Court, a jury found that his death was a result of misadventure but noted that his diagnosis of paranoid schizophrenia would have "contributed" to his death.Earlier in the week, the inquest heard that Mr James, who was born in Lowestoft, Suffolk, had a history of mental health issues.
The court heard that Mr James had been out on two hours of unescorted leave from Northgate Hospital in the town, where he was a patient, at the time of the incident.Speaking after the inquest, his brother Michael described Mr James as having a "happy, cheeky smile."Area coroner Samantha Goward praised the family for listening to "the worst of evidence with incredible dignity".His medical cause of death was recorded as traumatic brain injury and adult respiratory distress syndrome after an unwitnessed fall.
If you have been affected by this story, you can find organisations which offer help, support and information at the BBC Action Line
Follow Norfolk news on BBC Sounds, Facebook, Instagram and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
an hour ago
- The Sun
Over half of Brits feel lonely at least once a month… but are ashamed to admit it, study shows
OVER half of Brits feel lonely at least once a month – but are ashamed to admit it. A poll of 2,000 adults revealed 56 per cent would rarely or never consider talking to someone else about how isolated they felt. 2 Reasons for this included not wanting to burden others (37 per cent), not believing anyone else will understand (21 per cent), and not wanting to appear vulnerable (21 per cent). This may be a reflection on the strength of their support networks, as a quarter (24 per cent) described theirs as lacking – and a further 13 per cent didn't have one at all. Instead, those who feel lonely are likely to distract themselves through entertainment, such as watching TV (47 per cent), going on social media (22 per cent), or listening to the radio (19 per cent). The research was commissioned by audio brand, Pure, which is partnering with Marmalade Trust, a Bristol -based charity dedicated to raising awareness of loneliness and helping people build meaningful connections. As part of this partnership and in support of Loneliness Awareness Week, Pure will be donating 150 radios to individuals across the UK who are looking for support through a period of loneliness. Dr Lalitaa [COR], behaviouralist psychologist and expert in emotional wellbeing, commented: 'Loneliness remains a taboo subject, often shrouded in shame and stigma. 'But human connection is a basic psychological need – one that's increasingly difficult to fulfil in today's fast-paced, digital world. 'It's encouraging to see initiatives like this that provide simple, tangible comfort and help people feel part of something again.' Tara Fisher, COO from Marmalade Trust added: "Loneliness is a natural human emotion that we are all likely to experience in our lifetime. 'But there is still a stigma around loneliness, which means a significant portion of the population are reluctant to speak about these feelings to others – either because they don't feel they have anyone to talk to or are worried about doing so.' Despite these feelings of shame around loneliness, nearly eight in 10 (79 per cent) acknowledged it as a common phenomenon among the general population. Women were also found to feel lonelier than men – with only 16 per cent of women saying they never feel lonely, compared to 26 per cent of men. But perceptions about the generations most affected were not entirely accurate – with 19 per cent of all respondents believing the Silent Generation (born 1928-1945) is impacted the most by loneliness. However, Gen Zs (born 1996-2011) specifically reported feeling lonelier than any other age group, with one third feeling this way a few times a week and 11 per cent even experiencing this every single day. This compares to 19 per cent of the whole population dealing with this a few times a week and only six per cent every day. Worries about being judged (25 per cent) and dismissed (21 per cent) were also higher among Gen Zs – as were desires to socialise more (53 per cent) and make more friends (42 per cent). This compares to the 'famously lonely' Silent Generation – four in 10 of whom reported usually only going an hour maximum without speaking to someone else. A fifth of all those asked agreed on one day as the limit for not speaking to another person before feeling lonely – yet 23 per cent go this long, or longer, without talking to anyone regularly. Regionally, Londoners were most likely to report feeling lonely – with 33 per cent of those living in the capital saying they feel lonely at least a few times a week. Nearly four in 10 (39 per cent) of all respondents also claimed to feel lonelier now than they did five years ago, primarily because it's now harder to meet people. Other reasons included changes in personal relationships (23 per cent), financial stress (22 per cent), and lower self-esteem (20 per cent). The top locations people reported feeling lonely were also established as at home alone (59 per cent), in a crowd (27 per cent), and when having a meal by themselves (26 per cent). Perhaps to stave off this lonely feeling, over half (52 per cent) are more likely to listen to the radio when at home alone, according to data. Other than listening to the news and their favourite music, 38 per cent utilise their broadcast boxes for background noise (38 per cent), company (20 per cent), and making the house feel less quiet (19 per cent). A further 16 per cent specified listening to the radio helps them to feel less lonely, with 15 per cent liking to hear the sound of other people's voices, and 13 per cent enjoying being part of the conversation. Stations providing the best company were also identified as pop music (30 per cent), oldies music (24 per cent), and talk radio stations (21 per cent). Hubert Eiter, spokesperson for Pure, which is donating £5 for every Pure radio sold between June 9 – July 9, 2025 in support of Marmalade Trust, said: 'Pure has been active in supporting loneliness charities over many years and we are proud to partner with the Marmalade Trust this year. 'It's great to see that everyday listening can bring a lot of comfort to people, as it has the power to immediately make a room feel livelier and less quiet – we love the fact that radio is able to provide some company for those who feel lonely from time to time.' 2
The Independent
an hour ago
- The Independent
NHS trust cleared of corporate manslaughter after death of woman
An NHS trust has been cleared of corporate manslaughter after a young woman killed herself in a mental health unit after more than 10 similar attempts at self-harm. Jurors at the Old Bailey last Wednesday found that North East London NHS Foundation Trust (NELFT) was not responsible for the death of Alice Figueiredo, 22, but had 'failed to ensure the safety of a non-employee', it can now be reported. On Monday, ward manager Benjamin Aninakwa, 53, of Grays in Essex, was cleared of manslaughter by gross negligence, but was found guilty of failing to take reasonable care for the health and safety of patients on the ward. Jurors deliberated for 125 hours and 22 minutes to reach their verdicts. Ms Figueiredo died at Goodmayes Hospital, Redbridge, on July 7 2015, after a failure to remove plastic items from the communal toilets in the Hepworth Ward that had been used in repeated earlier attempts at self-harm. The jury heard Ms Figueiredo had been a 'bright and gifted' woman, the head girl at her school who had set up a mentoring system to support her peers. Her family said she was loved for her 'warmth, kindness and joyful character', the court was told. She was first admitted to the Hepworth Ward in May 2012 with a diagnosis including non-specific eating disorder and bipolar affective disorder, jurors heard. During her time on the acute psychiatric ward, the trust failed to remove plastic items from the communal toilets or keep them locked, even though she repeatedly used the items to try to kill herself. She had used plastic from the toilets to self-harm on at least 10 previous occasions. However, the court heard of eight more incidents involving similar materials before Ms Figueiredo killed herself. The suicide attempts were recorded in ward notes and other hospital records. Aninakwa, who was subject to a performance improvement plan, had failed to remove plastic that could be used for self-harm and failed to ensure incidents of self-harm were recorded, considered and addressed, jurors heard. Aninakwa and the trust had denied wrongdoing but declined to give evidence. The nurse had denied knowing about all the previous suicide attempts and said what action he took was overruled by management. It was claimed on his behalf that there was heightened observation to prevent incidents of self harm, which mitigated the fact plastic material was not removed and the communal toilets not locked. The trust also denied knowledge of the incidents, claiming the ward had not reported them. The process of removing plastics from the communal toilets was complicated by issues of infection control and preventing staff from being exposed to hazardous material in the bins, such as needles. The investigation into Ms Figueiredo's death began in 2016 but charges were not brought until September 2023. The first corporate manslaughter trial against an NHS trust collapsed in 2016 after a judge ruled there was no case to answer. Maidstone and Tunbridge Wells NHS Trust was accused over the death of schoolteacher Frances Cappuccini, 30, the first prosecution of a health service body since the offence was introduced in 2008. She went into cardiac arrest and died after an emergency Caesarean section at Tunbridge Wells Hospital in Pembury, Kent, on October 9 2012. The sentence for corporate manslaughter is a fine of between £180,000 and £20 million depending on the size of the organisation. Judge Richard Marks KC thanked jurors for their 'immense hard work' and discharged them from jury service for the rest of their lives. He thanked Ms Figueiredo's parents for their attendance throughout the trial, saying: 'It speaks volumes for both of you, and the immense love you have for Alice.' 'I hope this provides some consolation and some closure,' he added.
Daily Mail
an hour ago
- Daily Mail
'After taking Mounjaro, my life fell apart': Women reveal disturbing side effects from jab that started within days
Women have reported terrifying mental health side effects after taking Mounjaro—the popular weight-loss injection used by thousands of people in the UK. Some describe sudden panic attacks, crippling anxiety and a sensation of 'tugging in the brain' after starting the drug. Mounjaro, along with similar treatments such as Ozempic and Wegovy, can help dieters lose up to 15 per cent of their body weight in a year. An estimated 1.5 million Britons used weight-loss jabs in March 2025 alone—and the new wave of jabs have been hailed as a breakthrough in the fight against obesity. But growing numbers of patients say they have experienced unexpected mental health symptoms—including insomnia, tremors, shortness of breath and tinnitus. Although these are not currently listed as official side effects for any of the three major jabs in the UK, an online support group for users suffering such symptoms has attracted more than 2,800 members. Three members—speaking anonymously to The Times—described the onset of debilitating anxiety, sleeplessness and panic attacks after starting Mounjaro. One said the anxiety felt like a kind of 'terror' she had never experienced before. The cases have prompted fresh questions over the safety profile of the medications as their use becomes more widespread. Charlotte Lloyd, 37, a social media manager from London and member of the online group, had anxiety symptoms so bad she found herself in A&E, The Times reported. Last autumn she gained weight during her fertility treatment, so she had a BMI high enough to qualify for the prescription weight-loss jab Mounjaro. While NHS access to the weight loss jab remain limited, the Mounjaro jab is widely available through online doctors and private clinics. To be eligible you must have a BMI of 30 or more, or a BMI between 27 and 30 (overweight) and a weight-related health condition such as prediabetes. Ms Lloyd said it was a simple process to access the jab privately through Asda Online Doctor by Zava—requiring her medical history, weight, height and some photographs. But her nightmare began within days of taking her first weekly 2.5mg dose, when she 'almost immediately' lost her appetite and started having difficulty sleeping. The next week after her second dose, she said 'the wheels fell completely off' when she 'stopped sleeping all together'. 'I tried sleeping pills, antihistamines—nothing worked. I may as well have been eating sweets. After two nights awake I started to feel like I was losing my mind,' she said. It wasn't just difficulty sleeping, three days after she started experiencing symptoms, she went to A&E when her 'heart was pounding nonstop'. In the hospital an ECG revealed her heart was above the normal resting heart rate for adults, which is between 60 and 100 beats per minute. But while it was 105bpm compared to her normal resting heart rate of 70bpm, the rhythm wasn't irregular, so she was discharged. 'I explained I hadn't slept in days and they basically told me to go home and have a bath,' she said. Despite still struggling to sleep, her GP was unable to help, as she had 'reached the limit of what she could prescribe'. Things got worse when she was hit by a series of panic attacks and tremors for five weeks—which she likened to 'swallowing an earthquake'. Although she had noted in her application for the medication she had experienced some anxiety and insomnia in the past, it was still approved. But the anxiety she now experienced she described as 'a physical terror I've never known. Like a switch had been flipped in my brain. 'I went into a constant state of fight-or-flight—like a bad drug trip that wouldn't end. I couldn't see how I was going to be able to survive it.' Initially signed off work unable to 'do anything' or even 'follow a conversation', she later resigned with her relationship ending that same week. The woman who said her life 'just fell apart', said: 'The way I see it, it's a roll of the dice as to how you're going to react to these drugs. 'If people knew that they could have potentially catastrophic mental and physical side-effects, they could make a more informed decision about taking them.' Ms Lloyd isn't the only one experiencing psychological side effects—another woman also found herself in A&E after taking the jab. Maria Edwards, ended up in hospital last year only 48 hours after taking her first dose of the Mounjaro jab. When her BMI was over 30, so she too qualified for the weight loss jab which got from the online doctor, MedExpress. 'I thought I was having a heart attack,' she said, but her scans, x-trays and bloods taken, all came back clear. She said: 'I've never had any mental health problems. I've never had a panic attack or anxiety. I've always been a laid-back person and now it's like everything is stressful. 'I get this thing that we've termed 'air hunger' where it's like I can't take a deep breath. If I'd have known Mounjaro could have mental health side-effects I never would have taken it.' The third woman, Julie Peters, a 31 year-old mother from Birmingham had a similar experience after getting the jab. She had a panic attack that lasted two hours on January 11, after taking the lowest dose, 2.5mg, of Mounjaro, once a week for two months. The mother went to A&E also thinking she was having a heart attack, but similarly she said: 'tests on my heart, kidneys, and for pancreatitis all came back clear. Ms Peters also described experiencing tremors, a 'tugging' sensation in her brain' and tinnitus—'The ringing in my ears has been constant, sometimes with multiple ringing sounds. 'The pressure and heaviness in my brain make me feel dull, disconnected and nauseous, and I also have a sensitivity to motion. 'I recently requested a brain MRI, and while the results came back normal, I am relieved yet uncertain about what to do next. It's incredibly suffocating,' she said. It follows a study published in January last year in the International Journal of Clinical Pharmacy which found 481 psychiatric events were linked to weight loss jabs. The 'seriousness of the adverse events warrants additional research' to explore the causual relationship,' said lead authors, Hajer Elkout and Mansour Tobaiqy. This was despite psychiatric events only accounting for 1.2 per cent of total reports associated with the active ingredients in weight loss medications. Anxiety, depression nor insomnia were listed as potential side effects by Asda Online Doctor by Zava or in the patient leaflet they refer patients to. The clinical governance team at the private pharmacist who stressed patient safety told The Times all applicants are required to give their medical history. This includes their GP details which they said enables the GP to inform them 'of any discrepancies or concerns they have with the prescription'. They added there are studies evidencing mental health can be improved with treatment, and no clinical-based-evidence of a negative impact 'they are aware of'. Last year a study published in the journal of Natural Medicine found taking semaglutide for weight loss or diabetes reduced the incidence of suicidal ideation. However, a more recent study found Ozempic and Mounjaro can raise the risk of depression and suicidal thoughts. However, Asda Online Doctor by Zava added: 'Our doctors, of course, will provide suitable advice to any particular patients of concern or who are managing complex mental health issues and may not be able to use the treatment appropriately alone. 'These patients, where necessary, will be signposted to their GPs for further support to manage their weight.' The manufacturers of Mounjaro, Eli Lilly, and of both Ozempic and Wegovy, Novo Nordisk told The Times patient safety was their top priority. 'We take any reports about patient safety seriously and actively monitor, evaluate and report safety information for all our medicines,' said Eli Lilly. With Novo Nordisk adding it welcomes: 'Independent research investigating the safety, efficacy and clinical utility of our products.' The two drug companies both highlighted that the UK regulatory agency had assessed the risk and benefits approving their respective drugs. Novo Nordisk added that independent analysis 'did not find an association between use of GLP-1RA medicines and the occurrence of increased risk of suicidal thoughts or actions.'
